|
2025
|
G/S
|
Pharmaceutical preparations for the treatment and prevention of obesity, cardiovascular diseases,... |
|
|
G/S
|
Pharmaceutical preparations for the treatment and prevention of cancer |
|
|
G/S
|
Pharmaceutical and biological preparations for human use. |
|
|
G/S
|
Pharmaceutical preparations for the treatment and prevention of oncological, hematological, metab... |
|
|
Invention
|
Medication error detection system.
Various embodiments are provided herein for checking proper i... |
|
|
Invention
|
Methods for detecting anti-drug antibodies.
In certain embodiments, the present invention provid... |
|
|
Invention
|
Modulators of bcl6 as ligand directed degraders.
Provided herein are compounds and compositions ... |
|
|
Invention
|
Sulfone pyridine alkyl amide-substituted heteroaryl compounds.
Compounds having the following fo... |
|
|
Invention
|
System for verifying accuracy of serially-connected drug modules in a combinatorial drug delivery... |
|
|
Invention
|
Methods of aav therapy.
This disclosure provides methods for identifying a subject suitable for ... |
|
|
Invention
|
Methods for regenerating chromatography resins.
The invention provides improved methods of regen... |
|
|
Invention
|
Methods of treating tumor.
The disclosure provides a method for treating a subject afflicted wit... |
|
|
Invention
|
Cancer immunotherapy by disrupting pd-1/pd-l1 signaling.
The disclosure provides a method for im... |
|
|
Invention
|
Compounds and their use for treatment of hemoglobinopathies. e.g.e.g., X1, X2, X3, X4, R1, R2, R3... |
|
|
Invention
|
Compounds and their use for treatment of hemoglobinopathies.
Disclosed herein are compounds and ... |
|
|
Invention
|
Substituted 3-(5-(6-aminopyridin-2-yl)-4-fluoro-1-oxoisoindolin-2-yl)piperidine-2,6-dione compoun... |
|
|
Invention
|
Compounds for the degradation of alk proteins. Provided herein are compounds and compositions the... |
|
|
Invention
|
Process of preparing repotrectinib. Disclosed are process for preparing repotrectinib, compound o... |
|
|
Invention
|
Treatment of renal cancer using a combination of an anti-pd-1 antibody and another anti-cancer ag... |
|
|
Invention
|
Kaplan-meier digitizer for automating kaplan-meier curve analysis. A method (1100) includes recei... |
|
|
Invention
|
Kaplan-meier digitizer for automating kaplan-meier curve analysis.
A method includes receiving a... |
|
|
Invention
|
Novel fak degrader compounds and uses thereof. Provided herein are compounds and compositions the... |
|
|
Invention
|
Macrocyclic peptides. In accordance with the present disclosure, macrocyclic compounds have been ... |
|
|
Invention
|
Macrocyclic peptides useful as immunomodulators. In accordance with the present disclosure, macro... |
|
|
Invention
|
Antifoam compositions and methods of use thereof. The present disclosure provides compositions an... |
|
|
Invention
|
Tricyclic tlr7 agonists and uses thereof.
Compounds according to Formula (I) are useful as agoni... |
|
|
Invention
|
Bicyclic tlr7 agonists and uses thereof. Compounds according to Formula (I) are useful as agonist... |
|
|
Invention
|
Bicyclic tlr7 agonists and uses thereof.
Compounds according to Formula (I) are useful as agonis... |
|
|
Invention
|
Tricyclic tlr7 agonists and uses thereof. Compounds according to Formula (I) are useful as agonis... |
|
|
Invention
|
Anti-ceacam5 antibodies and uses thereof. Provided herein are isolated anti-CEACAM5 antibodies, a... |
|
|
Invention
|
Anti-ceacam5 antibody drug conjugates. Provided herein are antibody drug conjugates of the formul... |
|
|
Invention
|
Anti-ceacam5 antibody drug conjugates.
Provided herein are antibody drug conjugates of the formu... |
|
|
Invention
|
Anti-cd33 antibodies and uses thereof. The present application relates to particular anti-CD33 an... |
|
|
Invention
|
Antisense oligonucleotides targeting alpha-synuclein and uses thereof.
The present disclosure re... |
|
|
Invention
|
Antibodies against tim3 and uses thereof.
Provided herein are antibodies, or antigen-binding por... |
|
|
Invention
|
Piston valving for serially connectable drug modules of a combinatorial drug delivery device.
A ... |
|
|
Invention
|
Enhancing anti-cancer activity of immunomodulatory fc fusion proteins.
The present disclosure pr... |
|
2024
|
Invention
|
Amide-substituted heterocyclic compounds useful as modulators of il-12, il-23 and/or ifn alpha re... |
|
2023
|
Invention
|
Kras inhibitors.
The present disclosure provides KRAS inhibitors. Methods of treating cancers us... |
|
|
Invention
|
Antibody compositions and methods of use thereof.
The disclosure provides pharmaceutical composi... |
|
|
Invention
|
Drug delivery device with hidden marking.
The subject invention is for use with various drug del... |
|
|
Invention
|
Combination therapy using a substituted pyrimidin-4(3h)-one and nivolumab as well as its use in t... |
|
|
Invention
|
Processes for preparation of 3-d printed pharmaceutical products.
This invention relates to meth... |
|
|
Invention
|
Macrocyclic immunomodulators.
In accordance with the present disclosure, macrocyclic compounds h... |
|
2022
|
Invention
|
Rxfp1 agonists.
The disclosure relates to compounds of Formula (I), which are RXFP1 receptor ago... |
|
|
Invention
|
Use of sucrose, mannitol and glycine to reduce reconstitution time of high concentration lyophili... |
